Jerome Landry, MD, is professor of radiation oncology at Emory University School of Medicine and head of the IGRT Body Radiosurgery Program. He specializes in the treatment of gastrointestinal tumors and soft tissue sarcomas.

Dr. Landry is a graduate of Xavier University and Harvard Medical School. He completed his internship at Emory University Hospital and his residency in radiation medicine at Harvard's Massachusetts General Hospital, where he served as chief resident in his final year. He has served as medical director of the Edward Loughlin Radiation Oncology Center of Grady Health Systems since 1987. Dr. Landry also holds a MBA from Kennesaw State University.

Dr. Landry is currently developing image-guided body radiosurgery techniques for liver, hepatobiliary, and pancreatic tumors. He was the first to use Varian's Trilogy On-Board Imaging (OBI) system for gastrointestinal tumors. Dr. Landry has performed on-site IMRT training at more than 40 radiation oncology centers in the US and abroad.

Dr. Landry is Board Certified in radiation oncology and a clinical member of the Winship Cancer Institute. He is also a member of the Radiation Therapy Oncology Group, the American Medical Association, the Atlanta Medical Association, the Medical Association of Georgia, the American Society for Therapeutic Radiation and Oncology, the Collaborative Ocular Melanoma Society, the Radiological Society of North America, and the American Radium Society, among others. He has served on various committees, including the Georgia Cancer Coalition and the Federal Drug Agency Radiological Devices Patent Committee. Dr. Landry has won numerous awards and grants, and he has been ranked one of the best doctors in America by a number of publications and critics, including Atlanta Magazine (1995, 1997, 1998 & 2000), Red Book Magazine (2001), and Ladies Home Journal (2002). He has published extensively on IMRT for gastrointestinal tumors and soft tissue sarcomas, been an invited speaker at a number of medical and academic conferences, and is the lead editor for a chapter describing the use of IMRT in the treatment of pancreatic cancer in the textbook Intensity Modulated Radiation Therapy: A Clinical Perspective, published by BC Decker in 2005.

Degrees

• M.B.A., Kennesaw State University, Kennesaw, Georgia, 1998
• M.D., Harvard Medical School, Boston, Massachusetts, 1983
• B.S., Xavier University, New Orleans, Louisiana, 1978

Certification

• American Board of Radiology, Therapeutic Radiology, 1988

Training

• Residency in Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, 1984-7
• Internship in Internal Medicine, Emory University Hospital, Atlanta, Georgia, 1983-4

• Gastrointestinal malignancies
• Sarcomas
• Intensity-Modulated Radiation Therapy

• Burri S, Landry J, Davis L. Conservative Treatment of Breast Cancer: A Black/White Outcome Comparison. Journal of National Medical Association. July 2004.
• Harris W, Staley C, Landry J, Harris W, et al Neoadjuvant Induction Chemotherapy Followed by Chemoradiation: A Phase I Trial of Gemcitabine, Cisplatin, and 5-Flurouracil for Advanced Pancreatic/gastrointestinal Malignancies. Surg Oncol Clinic N Am. Vol 13, pp 697-709, 2004
• Koshy M, Landry J, et al. Multiple Management Strategies in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches. Oncologist. Vol 9, No. 2, pp 137-146, 2004.
• Koshy M, Landry J, et al. Multiple Management Strategies in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches. Oncologist. Vol 9, No. 2, pp 147-149, 2004.
• Koshy M, Landry J, et al. Current Controversies in the Management of Esophageal Cancer. Submitted to Journal of Oncology
• Esiashvilli N, Koshy M,. Landry J. IMRT Review. Current Problems in Cancer. Mar-April, pp 47-84, 2004.
• Koshy M, Landry J, Lawson J. Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma: A Case for Dose Escalation and Organ at Risk Toxicity Reduction. Sarcoma. Vol 7, No. 3/4, pp 137-148, 2005
• Rich T, Crane C, Landry J. Chemoradiation for Gastrointestinal Cancers. Current Oncology Reports. Vol 7, No. 1, pp 196-202, May 2005.
• Koshy M, Landry J, et al. State of the Art: Gastrointestinal Malignancies in the HIV Population. International Journal of Gastrointestinal Cancer. Vol 36, No 1, pp 1-14, 2005.
• Fox T, Crocker I, Landry J, et al. Clinical implementation and efficiency of kilovoltage image-guided radiation therapy (IGRT). Journal of the American College of Radiology. In press.
• Kauh J, Koshy M, Gunthel C, Landry J, Thomas C. Management of Anal Cancer in the HIV-Positive Population. Oncology. Vol 19, No. 12, pp 1634-1638, 2005.
• Perkins T, Landry J, etal The Role of Image Guided Radiation Therapy in Gastrointestinal Cancer published in the Journal of the Pancreas, October 2006.
• Anderson, C Landry J etal The Role of PET/CT in the Management of Rectal and Anal Cancer Accepted to the International Journal of Radiation Oncology Biology and Physics 4/07 in press
• Rosenthall, D; Landry J et al Phase I trial of Preoperative Radiation with Oxaliplatin and 5FU in Locally advanced Rectal Cancer Submitted JCO 5-07
• Kauh J Landry J. Preoperative Radiation with Oxaliplatin and 5FU in Locally advanced Rectal Cancer; the Emory Experience: Submitted to the Journal of Gastroenterology
• Landry JC, Yang G, et al Pure tubular breast carcinoma: A 34 year study of outcomes. TBJ-00027-2007.R2
• Lawson, J Landry J CCC07078OC Early Clinical Results from Chemoradiation With 5-FU and Oxaliplatin for Locally Advanced Rectal Cancer Accepted Clinical Colorectal Cancer In press 2/08